STOCKHOLM March 25, 2019 /PRNewswire/ — AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it will have two presentations at AD/PD 2019, the 14th International Conference on Alzheimer’s & Parkinson’s Diseases, March 26-31 , in Lisbon, Portugal.